Antibiotic resistance in Burkholderia cepacia at two regional cystic fibrosis centres in Northern Ireland: Is there a need for synergy testing? [4]

Journal of Antimicrobial Chemotherapy

Volumn 48, Issue 2, 2001, Pages 319-321

  Moore, John E ^a   Crowe, Mary ^a   Shaw, Adrienne ^a   McCaughan, John ^b   Redmond, Aileen O B ^b   Elborn, J Stuart ^a  

^a BELFAST CITY HOSPITAL   (United Kingdom)

^b ROYAL BELFAST HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; AZLOCILLIN; AZTREONAM; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; RIFAMPICIN; TEMOCILLIN; TOBRAMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL COLONIZATION; BURKHOLDERIA CEPACIA; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DRUG ANTAGONISM; DRUG POTENTIATION; HUMAN; IRELAND; LETTER; NONHUMAN;

ADULT; BURKHOLDERIA CEPACIA; BURKHOLDERIA INFECTIONS; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; DRUG RESISTANCE; HUMANS; NORTHERN IRELAND;

EID: 0034890932     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (4)

1. Multiple combination bactericidal antibiotic testing for patients with cystic fibrosis infected with Burkholderia cepacia
2. Burkholderia cepacia infections in cystic fibrosis
3. Speciation of the B. cepacia complex directly from CF sputum
4. Comparison of methods for assessing synergic antibiotic interactions